Table 1.
Evaluation of distant metastasis in the orthotopic experimental model of endometrial cancer.
| Lymph nodes | Bladder | Spleen | Liver | Diaphragm | Lung | |
|---|---|---|---|---|---|---|
| Hec1A control | 5/5 (100) | 3/5 (60) | 1/5 (20) | 0/5 (0) | 1/5 (20) | 1/4 (25) |
| Hec1A low LH | 4/4 (100) | 2/4 (50) | 0/4 (0) | 0/4 (0) | 0/4 (0) | 0/4 (0) |
| Hec1A-LH-R control | 9/9 (100) | 7/9 (78) | 2/9 (22) | 0/9 (0) | 3/9 (33) | 6/6 (100) |
| Hec1A-LH-R low LH | 8/8 (100) | 6/8 (75) | 2/8 (25) | 0/8 (0) | 2/8 (25) | 4/5 (80) |
Screening for macrometastases in different organs of mice involved in the orthotopic experimental model of endometrial cancer. In the left column are reported the group of mice and different cell lines injected and treatment used. The number of mice with macrometastases and the total number of mice analyzed are separated by slashes. Percentages of mice with macrometastases are reported in parenthesis.
The statistical significance of differences between experimental group was calculated with Kruskal–Wallis test (non-parametric ANOVA).